IGF‐I and testosterone levels as predictors of bone mineral density in healthy, community‐dwelling men
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: objective Age‐related decline in IGF‐I and gonadal hormones have been postulated to play an important role in the pathogenesis of age‐related bone loss in men. In this cross‐sectional study, the relation between serum IGF‐I and gonadal hormones with bone mineral density (BMD) was examined in community‐dwelling men. design and subjects Serum IGF‐I, testosterone and BMD were examined in 61 community‐dwelling men over the age of 27, who were randomly selected from the Calgary cohort of 1000 subjects in the Canadian Multicentre Osteoporosis Study. In the present study, IGF‐I, serum testosterone, SHBG, free androgen index (FAI), parathyroid hormone (PTH), 25‐hydroxy‐vitamin D [25(OH)D] and other markers of bone turnover were measured. BMD was measured at the spine and hip (HOLOGIC 4500). Simple linear regression was used to assess the linear relation between IGF‐I, testosterone, BMD and other biochemical markers of bone metabolism and potential confounding variables and subsequent multivariate regression models were constructed separately for each BMD measurement to assess the importance of IGF‐I and testosterone in the presence of potential confounding variables. results Serum IGF‐I, FAI and SHBG significantly decreased as a function of age, whereas serum levels of PTH increased. Only 25(OH)D, total testosterone and FAI were positively associated with serum IGF‐I after adjusting for age and BMI. Multiple linear regression models revealed that IGF‐I was a significant predictor of BMD at the total hip, femoral neck and femoral trochanter neck (P ≤ 0·001). In contrast, the FAI was a significant predictor of BMD at the lumbar spine and wards area (P ≤ 0·011), and SHBG was a significant predictor at the total hip and femoral trochanter (P ≤ 0·045). conclusion These data support the hypothesis that the age‐related decline in bone mass in men is associated with declining levels of IGF‐I and testosterone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471 · cited 2×
“Low bone mass has been documented in males with rare genetic disorders of oestrogen deficiency either due to an oestrogen receptor missense mutation (Smith et al., 1994) or aromatase deficiency (Morishima et al., 1995).”
BackgroundSlemenda, C. W., Longcope, C., Zhou, L., Hui, S. L., Peacock, M., & Johnston, C. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119701 · Cited by 455 · cited 1×
“Several studies with large populations have shown bioavalibale oestradiol to be an independent predictor of BMD in men (Greendale & Edelstein, 1997; Slemenda et al., 1997; Khosla et al., 1998; van den Beld et al., 2000).”
BackgroundMeier, D. E., Orwoll, E. S., Keenan, E. J., & Fagerstrom, R. M. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb02308.x · Cited by 131 · cited 1×
“Furthermore, FAI was the only gonadal hormone that served as a significant predictor of bone mass, and this association was only found significant at the spine (Meier et al., 1987).”
Background
Cited by
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Aversa, A., Bruzziches, R., Francomano, D., Greco, E. A., Fornari, R., Luigi, L. D., Lenzi, A., & Migliaccio, S. (2012) · The Aging Male · doi:10.3109/13685538.2011.631230 · Cited by 108
“A number of epidemiological studies have shown that BMD in the aging male population is positively associated with endogenous androgen levels [4].”
BackgroundThe Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review
Petkus, D. L., Murray-Kolb, L. E., & De Souza, M. J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0706-2 · Cited by 92
Ethical and medical considerations of androgen deprivation treatment of sex offenders
Gooren, L. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1540 · Cited by 39
Metadata
- Authors
- Rucker, D., Ezzat, S., Diamandi, A., Khosravi, J., & Hanley, D. A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-03-16
- Volume
- 60
- Issue
- 4
- Pages
- 491-499
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1993914889
- Cited by
- 56
- References
- 4
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IGF‐I and testosterone levels as predictors of bone mineral density in healthy, community‐dwelling men. https://app.cochat.ai/papers/10.1111/j.1365-2265.2004.02006.x
- The paper
- Rucker, D., Ezzat, S., Diamandi, A., Khosravi, J., & Hanley, D. A. (2004). IGF‐I and testosterone levels as predictors of bone mineral density in healthy, community‐dwelling men. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2004.02006.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.